Ambulatory blood pressure, left ventricular mass and vascular phenotypes in relation to the endothelial nitric oxide synthase gene Glu298Asp and intron 4 polymorphisms in a population-based family study

Journal of Human Hypertension

Volumn 19, Issue 5, 2005, Pages 413-420

  Czarnecka, D ^a   Kawecka Jaszcz, K ^a   Stolarz, K ^a   Olszanecka, A ^a   Dembinska Kiee A ^a   Kiec Wilk B ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Atherosclerosis; Blood pressure; Genetics; Nitric oxide synthase

Indexed keywords

ASPARTIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GENOMIC DNA; GLUTAMINE;

ADULT; ALLELE; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; FAMILY STUDY; FEMALE; FEMORAL ARTERY; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HEART LEFT VENTRICLE MASS; HOMOZYGOTE; HUMAN; INTRON; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; PARENT; PHENOTYPE; POPULATION RESEARCH; PROGENY; PULSE WAVE; QUANTITATIVE ANALYSIS; RANDOMIZATION; STATISTICAL ANALYSIS; THICKNESS; ULTRASOUND;

ADOLESCENT; ADULT; AGE FACTORS; ALLELES; ARTERIOSCLEROSIS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CAROTID ARTERY, COMMON; CIRCADIAN RHYTHM; ECHOCARDIOGRAPHY; FEMALE; FEMORAL ARTERY; GENE FREQUENCY; GENOTYPE; HEART VENTRICLES; HUMANS; INTRONS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; NUCLEAR FAMILY; POLAND; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POPULATION SURVEILLANCE; PREVALENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VENTRICULAR FUNCTION, LEFT;

EID: 18644367518     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001837     Document Type: Article

References (50)

1. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-2012.
2. Duplain H, Burcelin R, Sartori C. Insulin resistance, hyperlipidaemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 2001; 104: 342-345.
3. Kuhlencordt PJ, Gyurko R, Han F. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 2001; 104: 448-454.
4. Soubrier F. Nitric oxide synthase genes. Candidate genes among many others. Hypertension 1999; 33: 924-926.
5. Oemar BS et al. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 1998; 97: 2494-2498.
6. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 2: 997-1000.
7. Huang PL et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995; 377: 239-242.
8. Forte P et al. Basal nitric oxide synthesis in essential hypertension. Lancet 1997; 349: 837-842.
9. Taddei S et al. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 1996; 94: 1298-1303.
10. Cayatte A, Palacino JJ, Horten K, Cohen RA. Chronic inhibition of nitric oxide production accelerates neo-intima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb 1994; 14: 753-759.
11. Tesauro M et al. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary disease: cleavage of proteins with aspartate vs glutamate at position 298. Proc Natl Acad Sci USA 2000; 97: 2832-2835.
12. Tsukada T et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Com 1998; 245: 190-193.
13. Wang XL et al. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothehial nitric oxide synthase gene. Nat Med 1996; 2: 41-45.
14. Kuznetsova T et al. Quality control of the blood pressure phenotype in the European Project on Genes in Hypertension. Blood Pressure Monit 2002; 7: 215-224.
15. Staessen JA, Fagard R, Amery A. Life style as a determinant of blood pressure in the general population. Am J Hypertens 1994; 7: 685-694.
16. 41st World Medical Assembly. Declaration of Helsinki: recommendations guiding physicians in biomedical research involving human subjects. Bull Pan Am Health Organ 1990; 24: 606-609.
17. van Ittersum FJ, IJzerman RG, Stehouwer CDA, Donker AJM. Analysis of twenty-four-hour ambulatory blood pressure monitoring: what time period to assess blood pressure during waking and sleeping. J Hypertens 1995; 13: 1053-1058.
18. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
19. Schiller NB et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367.
20. Devereux RB et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458.
21. Wendelhag I, Wiklund O, Wikstrand J. Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia. Ultrasonographic assessement of intima-media thickness and plaque occurence. Arterioscler Thromb 1993; 13: 1404-1411.
22. Wang XL et al. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 1996; 2: 41-45.
23. Shimasaki Y et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 1998; 31: 1506-1510.
24. The SAS Institute. The GENMOD Procedure, SAS Online Doc Version 7.1: SAS/STAT. The SAS Institute Inc.: Cary, NC, 2000, pp 1311-1411.
25. Abecasis GR, Cardon LR, Cookson WOC. A general test of association for quantitative traits in nuclear families. Am J Hum Genet 2000; 66: 279-292.
26. Abecasis GR, Cookson WOC, Cardon LR. Pedigree tests of transmission disequilibrium. Eur J Hum Genet 2000; 8: 545-551.
27. Allison DB. Transmission-disequilibrium test for quantitative traits. Am J Hum Genet 1997; 60: 676-690.
28. Waldman ID, Robinson BF, Rowe DC. A logistic regression based extension of the TDT for continuous and categorical traits. Ann Hum Genet 1999; 63: 329-340.
29. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990 s. Nature 1993; 362: 801-809.
30. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115-126.
31. Cooke JP. Role of nitric oxide in progression and regression of atherosclerosis. West J Med 1996; 164: 419-424.
32. Philip I et al. G894 T polymorphism in the endothelial nitric oxide synthase gene is associated with an enhanced vascular responsiveness to phenilephrine. Circulation 1999; 99: 3096-3098.
33. Leeson CPM et al. Glu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial function. Circ Res 2002; 90: 1153-1158.
34. Guzik TJ, Black E, West NE. Relationship between the G894T polymorphism (Glu298Asp variant) in endothelial nitric oxide synthase and nitric-oxide mediated endothelial function in human atherosclerosis. Am J Med Genet 2001; 100: 130-137.
35. Bots ML et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction. Circulation 1997; 96: 1432-1437.
36. Hodis HN et al. The role of carotid arterial intimamedia thickness in predicting clinical coronary events. Ann Intern Med 1998; 128: 262-269.
37. Lembo G et al. A common variant of endothelial nitric oxide synthase (Glu298Asp) is an independent risk factor for carotid atherosclerosis. Stroke 2001; 32: 735-740.
38. Karvonen J et al. Endothelial nitric oxide synthase gene Glu298Asp polymorphisms and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort. J Intern Med 2002; 251: 102-110.
39. Schmoelzer I et al. Lack of association of the Glu298Asp polymorphism of endothelial nitric oxide synthase with manifest coronary artery disease, carotid atherosclerosis and forearm vascular reactivity in two Austrian populations. Eur J Clin Invest 2003; 33: 191-198.
40. Markus HS, Ruigrok Y, Ali N, Powell JF. Endothehial nitric oxide synthase exon 7 polymorphism and ischaemic cerebrovascular disease and carotid atheroma. Stroke 1998; 32: 735-740.
41. Rudic RD et al. Direct evidence for the importance of endothelial-derived nitric oxide in vascular remodeling. J Clin Invest 1998; 101: 731-736.
42. Asakimori Y, Yorioka N, Tanaka J, Kohno N. Effect of polymorphism of the endothelial nitric oxide synthase and apolipoprotein E genes on carotid atherosclerosis in hemodialysis patients. Am J Kidney Dis 2003; 41: 822-832.
43. Lacohley P et al. Nitric oxide synthase gene polymorphisms, blood pressure and aortic stiffness in normotensive and hypertensive subjects. J Hypertens 1998; 16: 31-35.
44. Tsujita Y et al. Association analyses between genetic polymorphisms of endothelial nitric oxide synthase gene and hypertension in Japanese: The Suita Study. J Hypertens 2001; 19: 1941-1948.
45. Karvonen J et al. Endothehial nitric oxide synthase gene Glu298Asp polymorphisms and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort. J Intern Med 2002; 251: 102-110.
46. Benjafield AV, Morris BJ. Association analyses of endothelial nitric oxide synthase gene polymorphisms in essential hypertension. Am J Hypertens 2000; 13: 994-998.
47. Pulkkinen A et al. Intron 4 polymorphism of the endothehial nitric oxide synthase gene is associated with elevated blood pressure in type 2 diabetic patients with coronary heart disease. J Mol Med 2000; 78: 372-379.
48. Morita T et al. Effect of polymorphism of endothelial nitric oxide synthase gene in Japanese patients with IgA nephropathy. Clin Nephrol 1999; 52: 203-209.
49. Uwabo J, Soma M, Nakayama T, Kanmatsuse K. Association of a variable number of tandem repeats in the endothelial nitric oxide synthase gene with essential hypertension in Japanese. Am J Hypertens 1998; 11: 125-128.
50. Takaoka M et al. Association of the missense Glu298Asp variant of the eNOS gene with left ventricular hypertrophy and carotid atherosclerosis in patients with essential hypertension. Atherosclerosis 2001; 2: 42-43.